JOHNS HOPKINS UNIVERSITY for JOHNS HOPKINS UNIVERSITY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical drug price increases; 340B drug discount program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISA LINDAMOOD | — |
Science/Technology SCI
Biomedical research and innovation, H.R.6 21st Century Cures Act; Grant support for physician scientists
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH ANN FELDER | — |
| MELISA LINDAMOOD | — |
Budget/Appropriations BUD
FY17 appropriations; AHRQ and NIH budgets; Defense reconstructive transplant; Defense extreme materials
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH ANN FELDER | — |
| JEFFREY GROSSI | — |
| MELISA LINDAMOOD | — |
Health Issues HCR
Uniformed Services Family Health Plan; Stark Law modernization; In-vitro toxicology; Enzyme use for sterilization of ophthalmic instruments; Lyme disease
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISA LINDAMOOD | — |
| DAVID PARKER | — |
Medicare/Medicaid MMM
Graduate medical education funding; CMS Hospital Star Ratings; Part B Drug Demonstration Project; MACRA, H.R.2 Medicare Access and CHIP Reauthorization; Parental nutrition payment coverage
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH ANN FELDER | — |
| MELISA LINDAMOOD | — |
| DAVID PARKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.